Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Drug Resistance Updates | journal | 3.845 Q1 | 132 | 21 | 62 | 5642 | 1385 | 62 | 22.11 | 268.67 | |
2 | Advances in Cancer Research | journal | 1.651 Q1 | 109 | 40 | 99 | 7052 | 712 | 13 | 5.44 | 176.30 | |
3 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 3 | 5 | 524 | 2 | 5 | 0.00 | 174.67 | ||
4 | Experientia supplementum (2012) | journal | 0.433 | 11 | 19 | 54 | 2912 | 124 | 33 | 2.57 | 153.26 | |
5 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 2.352 Q1 | 159 | 153 | 228 | 23080 | 2537 | 227 | 10.75 | 150.85 | |
6 | Cancer and Metastasis Reviews | journal | 1.796 Q1 | 167 | 73 | 209 | 10721 | 1853 | 197 | 8.47 | 146.86 | |
7 | MedComm | journal | 25 | 51 | 38 | 6578 | 91 | 29 | 2.39 | 128.98 | ||
8 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 4 | 7 | 490 | 1 | 7 | 0.20 | 122.50 | ||
9 | Blood Reviews | journal | 2.799 Q1 | 112 | 90 | 156 | 10511 | 1524 | 155 | 10.52 | 116.79 | |
10 | Exploration of Targeted Anti-tumor Therapy | journal | 10 | 37 | 29 | 3587 | 46 | 27 | 1.59 | 96.95 | ||
11 | Ca-A Cancer Journal for Clinicians | journal | 56.204 Q1 | 211 | 38 | 121 | 3679 | 18513 | 78 | 192.18 | 96.82 | |
12 | Critical Reviews in Oncology/Hematology | journal | 1.478 Q1 | 144 | 265 | 550 | 25593 | 3677 | 543 | 6.46 | 96.58 | |
13 | Nature Reviews Cancer | journal | 16.955 Q1 | 505 | 105 | 337 | 9854 | 9592 | 186 | 27.84 | 93.85 | |
14 | Current Cancer Drug Targets | journal | 0.732 Q2 | 103 | 72 | 243 | 6575 | 863 | 231 | 2.78 | 91.32 | |
15 | Current Cancer Therapy Reviews | journal | 0.117 Q4 | 17 | 29 | 74 | 2524 | 26 | 65 | 0.41 | 87.03 | |
16 | Cancer Treatment Reviews | journal | 3.214 Q1 | 164 | 105 | 322 | 9134 | 4297 | 321 | 13.48 | 86.99 | |
17 | NAR Cancer | journal | 17 | 53 | 37 | 4464 | 180 | 36 | 4.86 | 84.23 | ||
18 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.629 Q3 | 52 | 42 | 88 | 3536 | 322 | 85 | 2.84 | 84.19 | |
19 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.598 Q3 | 112 | 32 | 81 | 2653 | 193 | 78 | 2.32 | 82.91 | |
20 | Recent Results in Cancer Research | book series | 0.130 Q4 | 63 | 32 | 115 | 2650 | 376 | 1 | 1.67 | 82.81 | |
21 | Hepatoma Research | journal | 14 | 78 | 128 | 6441 | 153 | 120 | 1.20 | 82.58 | ||
22 | Cancers | journal | 1.349 Q1 | 133 | 6342 | 6394 | 515698 | 42531 | 6261 | 6.47 | 81.31 | |
23 | Current Treatment Options in Oncology | journal | 1.347 Q1 | 66 | 116 | 264 | 9375 | 1443 | 259 | 5.29 | 80.82 | |
24 | Journal of Cancer Metastasis and Treatment | journal | 16 | 69 | 133 | 5482 | 345 | 127 | 2.59 | 79.45 | ||
25 | Expert Review of Anticancer Therapy | journal | 0.852 Q2 | 85 | 127 | 346 | 9854 | 1422 | 302 | 3.25 | 77.59 | |
26 | Molecular Cancer | journal | 6.896 Q1 | 196 | 162 | 477 | 12537 | 15669 | 446 | 35.77 | 77.39 | |
27 | Journal of Hematology and Oncology | journal | 4.241 Q1 | 144 | 199 | 433 | 15362 | 8406 | 425 | 19.97 | 77.20 | |
28 | International Journal of Oncology | journal | 1.105 Q2 | 139 | 139 | 926 | 10354 | 5305 | 926 | 5.61 | 74.49 | |
29 | Cancer journal (Sudbury, Mass.) | journal | 1.027 Q2 | 102 | 72 | 196 | 5096 | 641 | 178 | 1.92 | 70.78 | |
30 | World Journal of Gastrointestinal Oncology | journal | 0.761 Q2 | 42 | 156 | 271 | 11041 | 970 | 262 | 3.49 | 70.78 | |
31 | Hematology/Oncology Clinics of North America | journal | 0.903 Q2 | 95 | 87 | 278 | 6154 | 947 | 240 | 2.71 | 70.74 | |
32 | Seminars in Radiation Oncology | journal | 1.467 Q1 | 103 | 46 | 123 | 3233 | 685 | 114 | 5.22 | 70.28 | |
33 | Biologics: Targets and Therapy | journal | 0.832 Q2 | 47 | 40 | 48 | 2810 | 221 | 48 | 5.24 | 70.25 | |
34 | Current Oncology Reports | journal | 1.435 Q1 | 77 | 148 | 336 | 10313 | 2013 | 334 | 6.03 | 69.68 | |
35 | Trends in Cancer | journal | 3.456 Q1 | 90 | 115 | 305 | 8008 | 3447 | 294 | 11.48 | 69.63 | |
36 | Gastrointestinal Disorders | journal | 8 | 22 | 72 | 1501 | 77 | 68 | 1.07 | 68.23 | ||
37 | Cellular oncology (Dordrecht) | journal | 1.326 Q1 | 58 | 89 | 194 | 6059 | 1305 | 189 | 6.84 | 68.08 | |
38 | Cancer Letters | journal | 1.923 Q1 | 216 | 476 | 1352 | 32194 | 12422 | 1340 | 8.98 | 67.63 | |
39 | Immuno-Oncology and Technology | journal | 10 | 9 | 24 | 601 | 56 | 18 | 2.33 | 66.78 | ||
40 | Oncology Reviews | journal | 0.737 Q2 | 31 | 12 | 70 | 793 | 295 | 69 | 3.94 | 66.08 | |
41 | Current Hematologic Malignancy Reports | journal | 1.125 Q2 | 44 | 53 | 170 | 3498 | 753 | 170 | 4.33 | 66.00 | |
42 | Nature Reviews Clinical Oncology | journal | 11.764 Q1 | 217 | 125 | 515 | 8209 | 9963 | 230 | 17.32 | 65.67 | |
43 | Journal of Experimental and Clinical Cancer Research | journal | 2.350 Q1 | 120 | 361 | 978 | 23361 | 11402 | 977 | 11.40 | 64.71 | |
44 | Journal of the National Cancer Institute. Monographs | journal | 0.958 Q2 | 95 | 19 | 39 | 1226 | 172 | 36 | 4.41 | 64.53 | |
45 | Lung Cancer: Targets and Therapy | journal | 1.056 Q2 | 27 | 14 | 41 | 893 | 163 | 41 | 3.96 | 63.79 | |
46 | Cancer Communications | journal | 2.357 Q1 | 79 | 105 | 229 | 6574 | 2159 | 180 | 9.45 | 62.61 | |
47 | Seminars in Oncology | journal | 1.347 Q1 | 145 | 35 | 144 | 2191 | 759 | 130 | 5.04 | 62.60 | |
48 | Breast Cancer: Targets and Therapy | journal | 0.808 Q2 | 43 | 57 | 81 | 3526 | 413 | 80 | 5.36 | 61.86 | |
49 | Pigment Cell and Melanoma Research | journal | 1.234 Q1 | 120 | 88 | 220 | 5442 | 879 | 181 | 4.19 | 61.84 | |
50 | Cancer Nanotechnology | journal | 0.921 Q2 | 36 | 33 | 37 | 2004 | 295 | 35 | 7.46 | 60.73 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®